We were delighted to see Dr Martina Angi in the CureOM newsletter this month, following the 4th scientific meeting in Seattle. Excerpt below.
To keep up to date with future updates, sign up today via CureOM's website: http://www.melanoma.org/learn-more/eye-on-OM
CURE OM Science Update
CURE OM is supporting research to advance effective treatments, and ultimately a cure for ocular melanoma. CURE OM held its 4th scientific meeting at the Fred Hutchinson Cancer Center in Seattle in May. Like other CURE OM scientific meetings, this meeting brought together an international and interdisciplinary group of researchers to present and discuss the latest research and clinical trials in the field. More than fifteen institutions participated.
A highlight of the meeting included a new collaborative focus on understanding and targeting mutations in OM. Discussions focused on advancing clinical trials, developing treatment guidelines, and continuing to foster collaborations between different academic centers, the National Institutes of Health, and industry. For the first time, research currently funded by the MRF's CURE OM grants was presented - work from the laboratories of Dr. Levi Garraway and Dr. John Sondek was spotlighted for the meeting attendees.
In addition, CURE OM awarded the first-ever Gregg Stracks Award for Emerging Leaders in Ocular Melanoma during the meeting. The two recipients were Dr. Martina Angi and Dr. Mizue Terai. Dr. Angi works at University of Liverpool with Drs. Bertil Damato and Sarah Coupland, and Dr. Terai works at Thomas Jefferson University with Dr. Takamo Sato. Both physician-researchers show tremendous promise for significantly advancing the field of OM. Congratulations to Dr. Angi and Dr. Terai!
To keep up to date with future updates, sign up today via CureOM's website: http://www.melanoma.org/learn-more/eye-on-OM
CURE OM Science Update
CURE OM is supporting research to advance effective treatments, and ultimately a cure for ocular melanoma. CURE OM held its 4th scientific meeting at the Fred Hutchinson Cancer Center in Seattle in May. Like other CURE OM scientific meetings, this meeting brought together an international and interdisciplinary group of researchers to present and discuss the latest research and clinical trials in the field. More than fifteen institutions participated.
A highlight of the meeting included a new collaborative focus on understanding and targeting mutations in OM. Discussions focused on advancing clinical trials, developing treatment guidelines, and continuing to foster collaborations between different academic centers, the National Institutes of Health, and industry. For the first time, research currently funded by the MRF's CURE OM grants was presented - work from the laboratories of Dr. Levi Garraway and Dr. John Sondek was spotlighted for the meeting attendees.
In addition, CURE OM awarded the first-ever Gregg Stracks Award for Emerging Leaders in Ocular Melanoma during the meeting. The two recipients were Dr. Martina Angi and Dr. Mizue Terai. Dr. Angi works at University of Liverpool with Drs. Bertil Damato and Sarah Coupland, and Dr. Terai works at Thomas Jefferson University with Dr. Takamo Sato. Both physician-researchers show tremendous promise for significantly advancing the field of OM. Congratulations to Dr. Angi and Dr. Terai!
Pictured: Attendees of the MRF's CURE OM 4th Scientific Meeting in Seattle, WA
